Recommendations for the study and pharmacological management in adult patients with suspected infection by SARS-CoV-2 (COVID-19)
| Errataetall: |
CommentOn: JAMA. 2020 Oct 6;324(13):1330-1341. - PMID 32876694 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:37 |
|---|---|
| Enthalten in: |
Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia - 37(2020), 6 vom: 12. Dez., Seite 646-666 |
| Sprache: |
Spanisch |
|---|
| Weiterer Titel: |
Recomendaciones para el estudio y manejo farmacológico en pacientes adultos con sospecha de infección por SARS-CoV-2 (COVID-19) |
|---|
| Beteiligte Personen: |
Pérez Godoy, Jorge [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 16.04.2021 Date Revised 16.04.2021 published: Print CommentOn: JAMA. 2020 Oct 6;324(13):1330-1341. - PMID 32876694 Citation Status MEDLINE |
|---|
| doi: |
10.4067/S0716-10182020000600646 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM323998348 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM323998348 | ||
| 003 | DE-627 | ||
| 005 | 20231225185356.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||spa c | ||
| 024 | 7 | |a 10.4067/S0716-10182020000600646 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1079.xml |
| 035 | |a (DE-627)NLM323998348 | ||
| 035 | |a (NLM)33844805 | ||
| 035 | |a (PII)S0716-10182020000600646 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a spa | ||
| 100 | 1 | |a Pérez Godoy, Jorge |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Recommendations for the study and pharmacological management in adult patients with suspected infection by SARS-CoV-2 (COVID-19) |
| 246 | 3 | 3 | |a Recomendaciones para el estudio y manejo farmacológico en pacientes adultos con sospecha de infección por SARS-CoV-2 (COVID-19) |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 16.04.2021 | ||
| 500 | |a Date Revised 16.04.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentOn: JAMA. 2020 Oct 6;324(13):1330-1341. - PMID 32876694 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Adrenal Cortex Hormones |2 NLM | |
| 700 | 1 | |a Rosales Chacón, Ruth |e verfasserin |4 aut | |
| 700 | 1 | |a Bernal Ortiz, Fernando |e verfasserin |4 aut | |
| 700 | 1 | |a Luengo Messen, Cecilia |e verfasserin |4 aut | |
| 700 | 1 | |a Arancibia Henríquez, José Miguel |e verfasserin |4 aut | |
| 700 | 1 | |a Pavez Azurmendi, Daniela |e verfasserin |4 aut | |
| 700 | 1 | |a González Muñoz, Claudio |e verfasserin |4 aut | |
| 700 | 1 | |a Arancibia Hernández, Francisco |e verfasserin |4 aut | |
| 700 | 1 | |a Riquelme Oyarzún, Raúl |e verfasserin |4 aut | |
| 700 | 1 | |a Pérez Pérez, Regina |e verfasserin |4 aut | |
| 700 | 1 | |a Acuña Ávila, Mirta |e verfasserin |4 aut | |
| 700 | 1 | |a Chanqueo Cornejo, Leonardo |e verfasserin |4 aut | |
| 700 | 1 | |a Regueira Heskia, Tomás |e verfasserin |4 aut | |
| 700 | 1 | |a Fuenzalida, Luz María |e verfasserin |4 aut | |
| 700 | 1 | |a Hernández Mazurek, Rubén |e verfasserin |4 aut | |
| 700 | 1 | |a Arias Lucero, Mariana |e verfasserin |4 aut | |
| 700 | 1 | |a Impellizzeri Navarro, Paula |e verfasserin |4 aut | |
| 700 | 1 | |a Paredes Kunst, Cristian |e verfasserin |4 aut | |
| 700 | 1 | |a Pinto Claude, María Eugenia |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia |d 1997 |g 37(2020), 6 vom: 12. Dez., Seite 646-666 |w (DE-627)NLM092581005 |x 0717-6341 |7 nnns |
| 773 | 1 | 8 | |g volume:37 |g year:2020 |g number:6 |g day:12 |g month:12 |g pages:646-666 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.4067/S0716-10182020000600646 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 37 |j 2020 |e 6 |b 12 |c 12 |h 646-666 | ||